Modulatory effects of cannabinoids on brain neurotransmission
- 18 March 2019
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 50 (3) , 2322-2345
Abstract
Recreational and chronic cannabis use has been associated with a range of acute and chronic effects including; anti‐nociceptive actions, anxiety, depression, psychotic symptoms and neurocognitive impairments. The mechanisms underlying cannabinoid‐based drugs effects are not fully known but given the neuro‐modulatory functions of the endocannabinoid system, it seems likely that agonistic activity at the cannabinoid type‐1 receptors (CB1) might modulate the functions of other neurotransmitter systems. The present review has summarized the currently available pre‐clinical and clinical data on the interactions of CB1 and cannabinoid type‐2 receptors (CB2) with the central neurotransmitters; dopamine, serotonin, noradrenaline, GABA, glutamate and opioids. Acute and chronic exposures to cannabinoids exert pharmacological alterations in the mammalian brain that have profound implications for our understanding of the neuropharmacology of cannabinoid‐based drugs and their effects on mental health and the brain. A recent emergence uses of cannabis for medical purpose together with legalization and decriminalization of cannabis and increasing use of highly potent synthetic cannabinoids raise a growing concern over the effects of cannabinoids and their interaction with other neurotransmitters on physical and mental health.Keywords
This publication has 287 references indexed in Scilit:
- Glutamate Concentration in the Medial Prefrontal Cortex Predicts Resting-State Cortical-Subcortical Functional Connectivity in HumansPLOS ONE, 2013
- Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THCDrug and Alcohol Dependence, 2012
- Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography StudyBiological Psychiatry, 2012
- The role of the central noradrenergic system in behavioral inhibitionBrain Research Reviews, 2011
- Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cellsBrain Research, 2010
- Cannabinoid modulation of cortical adrenergic receptors and transportersJournal of Neuroscience Research, 2009
- Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortexNeuroscience Letters, 2008
- Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channelsNeurochemistry International, 2008
- Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspectiveBrain Research Reviews, 2007
- CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agentsClinical Immunology, 2007